COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity in inoperable locally advanced/metastatic urothelial carcinoma
COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity in inoperable locally advanced/metastatic urothelial carcinoma
Safety follow-up of the randomized, phase 3 study DESTINY-Breast03
Panitumumab plus mFOLFOX6 improves OS for RAS wild-type left sided mCRC
Avasopasem produces significant improvement of severe oral mucositis in head and neck patients
Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma
Cancer Services Delivery: Focus on India
War in Ukraine: Impacts on the Slovakian cancer care system
Inspiration Family: Challenges of the Ukrainian cancer charity on the frontline
War in Ukraine: Impacts on the Ukrainian cancer care system
War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges
War in Ukraine: Current and future impacts on the Romanian cancer care system
Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients